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When mice are exposed to external warmth, nitric oxide synthase (NOS1) neurons
in the median and medial preoptic (MnPO/MPO) hypothalamus induce sleep and
concomitant body cooling. However, how these neurons regulate baseline sleep and
body temperature is unknown. Using calcium photometry, we show that NOS1 neurons
in MnPO/MPO are predominantly NREM and REM active, especially at the boundary
of wake to NREM transitions, and in the later parts of REM bouts, with lower activity
during wakefulness. In addition to releasing nitric oxide, NOS1 neurons in MnPO/MPO
can release GABA, glutamate and peptides. We expressed tetanus-toxin light-chain
in MnPO/MPO NOS1 cells to reduce vesicular release of transmitters. This induced
changes in sleep structure: over 24 h, mice had less NREM sleep in their dark (active)
phase, and more NREM sleep in their light (sleep) phase. REM sleep episodes in the dark
phase were longer, and there were fewer REM transitions between other vigilance states.
REM sleep had less theta power. Mice with synaptically blocked MnPO/MPO NOS1
neurons were also warmer than control mice at the dark-light transition (ZT0), as well as
during the dark phase siesta (ZT16-20), where there is usually a body temperature dip.
Also, at this siesta point of cooled body temperature, mice usually have more NREM,
but mice with synaptically blocked MnPO/MPO NOS1 cells showed reduced NREM
sleep at this time. Overall, MnPO/MPO NOS1 neurons promote both NREM and REM
sleep and contribute to chronically lowering body temperature, particularly at transitions
where the mice normally enter NREM sleep.
Keywords: preoptic hypothalamus, nitric oxide, sleep, calcium photometry, body temperature, tetanus-toxin
light-chain
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INTRODUCTION
Numerous circuits dispersed throughout the brain induce NREM
sleep, but the preoptic (PO) hypothalamus, one of the first sleep-
promoting centers to be identified (Nauta, 1946), has a major
role (Sherin et al., 1996; Zhang et al., 2015; Weber and Dan,
2016; Chung et al., 2017; Kroeger et al., 2018; Ma et al., 2019;
Reichert et al., 2019; Reitz and Kelz, 2021). The PO area also
contains neurons that are required for REM sleep (Lu et al.,
2000), including REM-promoting cells in MPO (Suntsova and
Dergacheva, 2004; Gvilia et al., 2006). The PO area, which
contains a huge diversity of cells (Moffitt et al., 2018; Tsuneoka
and Funato, 2021), also contributes to regulating many other
functions, including nesting, thermoregulation, parenting, sexual
behavior, water consumption, blood osmolarity, and daily torpor
(Nakamura and Morrison, 2008, 2010; Morrison and Nakamura,
2011; Saper and Lowell, 2014; Abbott and Saper, 2017; Hrvatin
et al., 2020; Takahashi et al., 2020; Tsuneoka and Funato, 2021).
The medial (M) and median (Mn) PO hypothalamic areas
are enriched for neuronal nitric oxide (nos1) gene expression,
as seen by in situ hybridization in the Allen Brain Atlas
(Lein et al., 2007), and from our previous studies (Harding
et al., 2018). Previously we found that NOS1 neurons in the
MnPO and MPO area link NREM onset and the decrease
of body temperature that accompanies sleep (Harding et al.,
2018). We hypothesized that external warm sensing and NREM
sleep induction through these neurons may be part of an
energy conservation mechanism that optimizes sleep toward
thermoneutral temperatures (Harding et al., 2020).
In addition to presumably synthesizing NO in response to
excitation and calcium, MnPO/MPO NOS1 cells, depending
on subtype, likely release both GABA and glutamate and/or
various peptides (Moffitt et al., 2018). Here we show by calcium
photometry that NOS1 neurons in MnPO/MPO have their
highest activity during NREM sleep, becoming particularly active
at the boundary of wake to NREM transitions, and they are also
active during the latter parts of REM sleep episodes. Synaptic
silencing of MnPO/MPO NOS1 cells with tetanus toxin light-
chain (TeLC) expression induced bidirectional changes to NREM
sleep structure: over the 24-h cycle, mice had less NREM sleep
in the dark phase, and more in the light phase. Dark phase
REM sleep also consolidated to longer episodes, with a reduction
in REM transitions; however, both light- and dark-phase REM
sleep had more delta and less theta power than in controls,
possibly suggesting disrupted REM function. In addition, a shift
in the core body-temperature profile to warmer temperatures
and a disrupted siesta (ZT16-20) period were observed. Thus,
vesicular release of transmitters from MnPO/MPO hypothalamic




Experiments were performed under the Animals (Scientific
Procedures) Act (1986) and approved by the local ethics
committee. The mice used were Nos1-ires-CreTM1(crE)Mgmj/J
(JAX labs stock 017526), referred to here as Nos1-Cre mice,
donated by Martin G Myers (Leshan et al., 2012), and C57BL/6J
mice (supplied by Charles River United Kingdom). All mice
used in the experiments were male and congenic on a C57BL/6J
background. Mice were maintained on a reversed 12 h:12 h
light:dark cycle at constant temperature (22± 1◦C) and humidity
with ad libitum food and water.
AAV Transgenes and AAV Production
We used the following pAAV transgene plasmids: pAAV-
FLEX-GFP-TeLC (Murray et al., 2011), and pAAV-FLEX-GFP
(Addgene #28304, a gift from Edward Boyden). Plasmid
pAAV-FLEX-GCaMP6s was created by inserting the GCaMP6s
open reading frame from pCMV-GCaMP6s (Addgene plasmid
40753, gift of Douglas Kim) (Chen et al., 2013), into the
backbone of pAAV-flex-hM3Dq-mCHERRY (Krashes et al., 2011)
in place of the hM3Dq sequence, but retaining the loxP
sites. AAV transgenes were packaged in-house into capsids
with a 1:1 ratio of AAV1 and AAV2 capsid proteins. The
adenovirus helper plasmid pF16, the AAV helper plasmids pH21
(AAV1) and pRVI (AAV2), and the pAAV transgene plasmids
were co-transfected into HEK293 cells and AAVs harvested
on heparin columns, as described previously (Klugmann
et al., 2005; Yu et al., 2015). AAVs titers were determined
with an AAVpro Titration Kit (for real-time PCR) Ver. 2
(TakaRa Bio). The virus titers were as follows: AAV-FLEX-
GCaMP6s, 1.6 × 106 viral genomes/µl; AAV-FLEX-GFP-TeLC
5.1 × 105 viral genomes/µl; AAV-FLEX-GFP, 6.1 × 106
viral genomes/µl.
Surgeries and Stereotaxic Injections of
AAV
Mice underwent their first surgery at 10-weeks old. The mice
required two rounds of surgery including implantation of an
abdominal temperature logger, followed one week later by
stereotaxic injections of AAV virus and electrode placement
for electrocorticography (ECoG). For surgery, mice were
anesthetized with 2% isoflurane and given appropriate analgesia.
Viral infusions were performed using a steel injector (10 µl-
Hamilton #701) and the aid of an electronic pump. Injections
were optimized for the target with injection volumes of between
0.05 and 0.2 µl at 0.1 µl min−1. The injection coordinates
relative to Bregma were AP +0.34 mm, ML 0 mm, DV −4.8
and 5.2. A minimum of one week recovery was allowed before
recording the EEG.
EEG and EMG Recordings, Scoring of
Vigilance States and Power Spectrum
Analysis
EEG and EMG were recorded from non-tethered animals using
Neurologger 2A devices as described previously and electrodes
placed at the same positions as our previous work in mice
(Anisimov et al., 2014; Zhang et al., 2015). These positions were:
AP +1.5 mm, ML −1.5 mm relative to Bregma, 1st − AP
−1.5 mm, ML +1.5 relative to Bregma, 2nd Lambda −1.0 mm,
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ML 0.0 mm. EMG wires were also implanted in the neck muscles.
Data were recorded at a sampling rate of 200 Hz with four times
oversampling. The EEG data analyzed using Spike2 software 7.18
(Cambridge Electronic Design, Cambridge, United Kingdom) or
MATLAB (MathWorks, Cambridge, United Kingdom). Prior to
sleep scoring the ECoG was digitally filtered (high-pass, 0.5 Hz,
−3dB) and the EMG was band-pass filtered (5–45 Hz, −3dB).
Power in the delta (1–4 Hz) and theta (6–9 Hz) bands was
calculated, together with the RMS value of the EMG signal
(averaged over 5 s), and these were used to define the vigilance
states of wake, NREM and REM with an automatic script
OSD7 v7.2 (in Spike2). Each vigilance state was then rechecked
manually. We analyzed the sleep-state specific power spectrums
following normalization to wake power within each mouse, as
described previously (Ma et al., 2019).
Photometry Recordings
Photometry was performed using a 473-nm diode-pumped solid
state (DPSS) laser with fiber coupler (Shanghai Laser and Optics
century Co.) and adjustable power supply (Shanghai Laser and
Optics century Co.), controlled by a Grass SD9 stimulator.
A lock-in amplifier (SR810, Stanford Research Systems, CA,
United States) drove the laser using a TTL signal at 125 Hz
with an average power of 80 µW at the tip of the fiber.
Using an optical fiber patch cord (Ø 200 µm, 0.22 NA,
Doric Lenses) the light source passed through a fluorescence
cube (FMC_GFP_FC, Doric Lenses) and then via a second
optical patch cord (Ø 200 µm, 0.37 NA, Doric Lenses), was
connected to the brain-implanted fiber via a ceramic sleeves
(Thorlabs). The GCaMP6s output was then filtered at 500–
550 nm (using a fluorescence cube) and passed to a photodiode
(APD-FC, Doric Lenses) and amplified by the lock-in amplifier
(time constant, 30 ms). The signal was recorded on a CED
1401 Micro box (Cambridge Electronic Design, Cambridge,
United Kingdom) at 200 Hz using Spike2 software (Cambridge
Electronic Design, Cambridge, United Kingdom). The maximum
continuous recording length was 6 h. Photometry, EEG and
EMG data were aligned offline using Spike2 and analyzed
using this software or custom scripts in either MATLAB
(MathWorks) or R scripts (R Core Team, 2020). Peak counting
was performed using Spike2 (using peak mode), “Peaks” were
counted when immediately followed by a decrease of at least
the threshold amplitude (100 µV) and were outside the minimal
interval between detections of 10 ms. For each transition,
the photometry signal F was normalized to baseline using
the function 1F/F = (F−F0)/F0, where F0 is the baseline
fluorescence prior to the transition. Data are presented as
a percentage. Heatmaps are shown as Z-scores. Transitions
coinciding with recording artifacts or large shifts in baseline (DC
offset) were excluded.
Temperature Recordings
Core body temperatures were measured using an abdominally
implanted temperature loggers (DSTnano, Star-Oddi, Herfølge,
Denmark), sampling every 2 min, as described previously
(Harding et al., 2018).
Immunohistochemistry
Mice were given pentobarbital (100 mg/kg body weight; i.p.),
and transcardially perfused with 4% paraformaldehyde in
phosphate-buffered saline (PBS), pH 7.4. Brains were removed
and 40-µm-thick coronal sections cut using a Leica SM 2010R
microtome. Staining was performed on free-floating sections,
washed in PBS three times and permeabilized in PBS plus
0.4% Triton X-100 for 30 min, blocked by incubation in PBS
plus 10% normal goat serum (NGS), 0.2% Triton X-100 for
1 h (all at room temperature) and subsequently incubated
overnight with a 1:1000 dilution of anti-GFP polyclonal antibody
(A-6455, ThermoFisher). Sections were washed three times in
PBS before incubating with goat anti-Rabbit IgG (H + L)
Secondary, Alexa Fluor R© 488 conjugate (A-11034, ThermoFisher)
for 2 h. Samples were then washed six times before mounting
on Vectashield Antifade Mounting Medium with DAPI (H-1200,
Vector Laboratories).
Statistics
Data collection were either randomized or performed in
a counter-balanced manner. Data are represented as the
mean ± SEM, unless otherwise stated. OriginPro 2017 was used
for statistical analyses. For data that were not independent (where
ANOVA was not appropriate) we employed either two-tailed or
paired t-tests and then accounted for multiple comparisons using
the Benjamini-Hochberg procedure at a false discovery rate of
5%. Mice were excluded from the analysis if the histology did not
confirm AAV transgene expression in the MnPO/MPO area, or if
the expression had spread beyond the target region. Investigators
were not blinded to behavioral treatment groups.
RESULTS
Medial Preoptic Nitric Oxide Synthase 1
Neurons Are Most Active During NREM
Sleep
We used calcium photometry to assess the sleep-wake activity
of NOS1 neurons in the MPO area. AAV-FLEX-GCaMP6s was
injected into the MnPO/MPO area of Nos1-Cre mice to generate
Nos1-MnPO/MPO-GCaMP6s mice (Figures 1A,B). We then
recorded calcium photometry signals from mice over 6 h while
the mice behaved freely in their home cages. Many NOS1 neurons
in the MnPO/MPO region were NREM sleep-active, having
their highest calcium activity in NREM sleep with only sporadic
activity during wakefulness. An example over a 6-min period of
a transition to NREM sleep is shown in Figure 1C, alongside the
raw photometry signal, delta power (1–4 Hz), spectrogram from
0 to 20 Hz, EEG, EMG and scored sleep state. During wakefulness
only low-level calcium-induced fluorescence signal was seen
(labeled “F” on the axis of Figure 1C), and peaks in the signal
were rare. While occasional small peaks in the calcium signal
occurred during wake, a specific increase in peak frequency in the
calcium signal was associated with NREM sleep. This is shown as
a raster plot for ten transitions in Figure 1D over a 6-min period
and quantified in Figure 1E. Higher GCaMP6s signal levels and
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FIGURE 1 | MnPO/MPO hypothalamic NOS1 neurons are more active during sleep. Animals were recorded for 6 h across the light cycle from lights-off to lights-on
to facilitate a distribution of sleep states. Transitions are shown over 300 s. (A) Schematic for the photometry recording at a 5-mm depth and an example of the
GCaMP6 expression site in a Nos1-MnPO/MPO-GCaMP6s mouse. (B) Expression of GCaMP6s in neurons in the MnPO/MPO hypothalamus as detected by
immunocytochemistry with GFP antisera. (C) Example transition from wake to NREM over a 6-min interval. Also shown are scored sleep states (Wake, W; NREM, N;
REM, R), Filtered EEG and EMG, spectrogram of power in the frequency domain over time (Hz), Delta power (1–4 Hz) with a 5-s root mean square (RMS), raw
photometry signal (labeled F) and automated peak counting on the photometry signal (Peaks). (D) A raster plot of automated spike counting from calcium
photometry signals across wake to NREM transitions. (E) Area under the curve (1F/F) between wake and NREM for soft transitions in calcium signal (Paired t-test,
n = 5, p = 0.0001). (F) Raw photometry data with paired automated peak counting for four example transitions over 5 min, colored by sleep state. Wake is shown in
blue and NREM is shown in green. Peaks in calcium are marked above each trace. (G) The average 1F/F in calcium signal for soft-type transitions that increase
across wake-NREM transitions and ten example transitions represented as a heatmap. (H) 1F/F Area under the curve between wake and NREM for soft transitions
(Paired t-test, n = 5, p = 0.002). (I) The average 1F/F for sharp-type increases in calcium signal in wake-NREM transitions before returning to baseline, followed by
ten example transitions represented as a heatmap. (J) Mean 1F/F of the calcium signal between wake (baseline) and NREM (peak) for sharp transitions (Paired
t-test, n = 5, p = 0.004). (K) The z-score of 1F/F variance for mixed-type transitions in calcium signal that increase across wake-NREM transitions (F-test of all
pooled transitions, p = 3 × 10−7). Shown alongside ten example transitions in the calcium signal represented as a heatmap. (L) Quantification of variance in the
1F/F calcium signal in across mice (Paired t-test, n = 5, p = 0.021). (M) Proportion of each transition in calcium signal type (soft increase, sharp increase, mixed
increase) found in all wake to NREM transitions. Transitions in calcium signal that could not be classified are labeled NK. The Benjamini-Hochberg procedure was
used to account for multiple comparisons at a false discovery rate of 5%. *P < 0.05, **P < 0.01, ***P < 0.001.
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more frequent peaks occurred during NREM sleep. Four example
photometry traces are shown in Figure 1F and color coded by
sleep state. Peak counting is shown above each example.
On transitioning to NREM sleep the overall calcium levels in
MnPO/MPO NOS1 neurons increased, as did the frequency of
peaks in calcium signal. To quantify these changes in calcium
signals, we averaged across multiple wake-NREM transitions
from multiple mice. These averages contained several profiles:
a slower “soft” rising transition in calcium signal with more
peaks; and a faster “sharp” profile. Soft transitions from wake
to NREM sleep are shown in Figure 1G, plotted as 1F/F and
averaged across 5 min of recording, alongside a heat map of ten
example transitions. The 1F/F calcium signal started to rise from
the point of transition, and this continued for at least 150 s.
This is quantified as the area under the curve in Figure 1H.
On the other hand, sharp transitions in calcium-induced signals
in MnPO/MPO NOS1 were different and anticipated the next
NREM sleep transition. These sharp transitions are shown
in Figure 1I as 1F/F, alongside a heatmap of ten example
transitions. Here, the 1F/F signal started to rise up to 60 s
prior to the start transition and peaked within 30 s of entering
NREM sleep, before reducing again by 1 min post-transition.
The heatmap shows that these calcium events were time-locked
to the wake-NREM transitions. Within 100 s, the calcium signal
had almost returned to baseline, despite continuous NREM. This
was quantified as the mean amplitude between baseline and the
maximum value in Figure 1J. Both the soft and sharp transitions
in calcium signals had a slow time course that took more than
60 s to complete. The remainder of the calcium signals associated
with the transitions from wake to NREM sleep of MnPO/MPO
NOS1 neurons could not be classified into soft or sharp profiles.
However, when these remaining calcium signals at the wake to
NREM transitions were pooled and analyzed by variance, a clear
association with the wake to NREM transitions was seen. These
“mixed” transitions in calcium signals are shown in Figure 1K,
plotted as a Z score of the 1F/F variance, alongside a heatmap
of ten example transitions. Here, the variance in calcium signal
increased across the wake to NREM transitions in four of the
five animals measured (Figure 1L). Overall, on moving from
wake to NREM sleep, approximately 60% of changes in the
calcium signal of MnPO/MPO NOS1 were either soft or sharp
increases in signal, and 30% were mixed. Approximately 10% of
the recordings of calcium signals did not show changes in activity
during wake to NREM transitions (Figure 1M).
In addition to the increases in calcium signals of MnPO/MPO
NOS1 neurons on transition from wake to NREM, we also
looked at their calcium signals during transitions from NREM
to wake and from NREM to REM sleep (Figure 2). We found
that NREM sleep was sometimes interrupted with short bouts
of wake episodes lasting about one minute (micro-wakes). In
these short transitions, a small decrease in the calcium signal of
MnPO/MPO NOS1 neurons was seen on entry into wakefulness
that continued to decline until the next NREM episode and the
calcium signal increased once more (Figures 2A,B). In this case,
while we noted some clear examples, as shown in Figure 2C,
there were also large variations between animals and there was
insufficient statistical power to infer if these small decreases in
calcium signal were significant (Figure 2B). The calcium signals
in MnPO/MPO NOS1 neurons during the transitions from
NREM to REM are shown in Figure 2D and shown alongside a
heatmap of nine example transitions. As described above, once
NREM has commenced the calcium signal tends to decay to a
lower baseline (Figure 1I). At the transitions of NREM to REM,
the average 1F/F calcium signal remained at a low baseline
for at least 30 s into the REM bout (red bar in Figure 2D).
Following this there was an increase in the signal and plateau
that lasted approximately 60 s (Figures 2D,E), which continued
into micro-wake bouts before reentry into NREM (see examples
Figure 2F).
Medial Preoptic Nitric Oxide Synthase 1
Neurons Influence Sleep-Wake Structure
Having established that many NOS1 neurons in the MnPO/MPO
area are more active during NREM and REM sleep than they
are during wake, we next examined their contribution to sleep
structure. To do this we reduced synaptic transmission from these
cells, using Cre-dependent expression of tetanus-toxin light-
chain (GFP-TeLC) (Figure 3A). Tetanus-toxin light chain blocks
release of neurotransmitter vesicles by cleaving synaptobrevin, a
synaptic vesicle protein (Schiavo et al., 1992). AAV-FLEX-GFP-
TeLC or AAV-FLEX-GFP were injected into the MnPO/MPO
of Nos1-Cre mice to generate Nos1-MnPO/MPO-GFP-TeLC and
control Nos1-MnPO/MPO-GFP mice, respectively (Figure 3B).
Reducing synaptic transmission from NOS1 neurons produced
small but significant alterations to the structure of sleep
(Figure 3C). These data are quantified for each mouse. Average
wakefulness was reduced by almost 25% during the light phase,
with a corresponding increase in NREM of approximately 10%.
This was followed by an approx. 15–20% decrease in NREM
during lights OFF. No clear changes were seen in REM sleep time.
We assessed whether changes in sleep structure seen in Nos1-
MnPO/MPO-GFP-TeLC mice affected sleep episode dynamics
and/or transitions (Figure 3D). There were no changes in the
overall number of episodes in wake or NREM sleep for either
the light or dark phase of the cycle; however, there was an
approximately 45% reduction in REM episodes in the dark phase
(Figure 3D). Consistent with this result, the number of NREM-
REM and REM-wake transitions, but not transitions between
wake and NREM sleep, were reduced by approximately 40%. No
changes were seen in the light phase (Figures 3E,F). Although
this was not reflected in the REM sleep amount, it was consistent
with less NREM in the dark phase. In addition, we expected the
remaining REM sleep to be consequently more consolidated.
Because we did not observe an overall change in the number
of wake or NREM episodes during the light or dark phase, we
looked at the episode length and number of vigilance states
to see if this explained the differences seen in the time spent
sleeping (Figure 4). In Nos1-MnPO/MPO-GFP-TeLC mice we
observed reductions of approximately 50% in the frequency of the
longest wake episodes (>20 min) in the light phase (Figure 4A),
although no changes were seen in episode length and number
for NREM and REM sleep (Figures 4B,C). In the dark phase,
the average values for wake did not change, and the data had
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FIGURE 2 | MnPO/MPO hypothalamic NOS1 neurons are active during the later part of REM episodes. Animals were recorded for 6 h across the light cycle from
lights-off to lights-on to facilitate obtaining a distribution of sleep states. Transitions are shown over 180 s. (A) The average 1F/F in calcium signal when NREM is
interrupted by short bouts of wake. Wake length here is approximated and followed by ten example transitions, represented as a heatmap. (B) Mean change in 1F/F
calcium signal between brief wakefulness, prior-NREM and post-NREM for short transitions (Paired t-test, n = 4, prior-NREM vs. brief wakefulness, p = 0.063,
post-NREM vs. brief wakefulness p = 0.076). (C) Examples of NREM to wake transitions from raw photometry data colored by sleep-state (NREM, green; REM,
cyan and wake, blue). (D) The average 1F/F for NREM to REM transitions showing no clear changes in signal with a slower increase after approximately 30 s
alongside a heat map of nine transitions from NREM to REM sleep. (E) Mean change in 1F/F calcium signal between the end of a NREM period and the later part of
a REM episode (Paired t-test, n = 5, p = 0.066) and NREM and post-REM (Paired t-test, n = 5, p = 0.034). (F) Examples of calcium signals during NREM to REM
to microwake to NREM transitions, colored by sleep-state (NREM, green; REM, cyan; wake, blue). **P < 0.01, n.s, not significant.
larger variance (Figure 4D). However, while Nos1-MnPO/MPO-
GFP control mice had a reduced frequency of episodes, >20 min
in the dark phase compared with the light phase, the Nos1-
MnPO/MPO-GFP-TeLC mice instead had an increased frequency
of these episodes. From calculating the paired difference for each
mouse between the light and dark phase, it was clear that Nos1-
MnPO/MPO-GFP-TeLC mice were more affected by the light
change (Figure 4D, inset graph). No further alterations were seen
in episode length and number for NREM and REM sleep during
lights OFF (Figures 4E,F).
Medial Preoptic Nitric Oxide Synthase 1
Neurons Contribute to Theta Power
During REM Sleep
We analyzed the sleep-state specific power spectra of Nos1-
MnPO/MPO-GFP-TeLC mice compared with Nos1-MnPO/MPO-
GFP control mice, following normalization to WAKE power
within each mouse. During the lights-on phase, NREM sleep
was not associated with changes in power (Figures 5A,B);
however, REM sleep did show significant changes (Figure 5C).
Specifically, there was an increase in delta power, normally
associated with NREM sleep, of approximately 30%, as well
as a corresponding decrease in theta power (Figure 5D).
This difference was in the 2–4 Hz range of delta power
referred to as the δ2 band (Hubbard et al., 2020). Theta
(6–9 Hz) power was reduced by approximately 20% but no
changes in the higher frequencies (10–14 Hz) were seen.
During the dark phase (Figures 5E,F), NREM showed an
approximately 15% reduction in theta power. This contrasted
with no change in this band during the light phase. For
REM sleep in the dark phase (Figures 5G,H), differences
between Nos1-MnPO/MPO-GFP-TeLC and Nos1-MnPO/MPO-
GFP mice mirrored those seen in the light phase, with an
approximately 25% increase in δ2 power as well as a 20%
decrease in theta power.
Medial Preoptic Nitric Oxide Synthase 1
Neurons Reduce Body Temperature
Using implanted temperature loggers, we measured the core body
temperature at 2-min resolution in Nos1-MnPO/MPO-GFP-TeLC
and Nos1-MnPO/MPO-GFP mice (Figure 6). We produced a
typical 24-h period in temperature change by first averaging over
7 days for each mouse (5040 measurements) before comparing
distributions across groups. The temperature distribution
of Nos1-MnPO/MPO-GFP-TeLC mice shifted to warmer
temperatures compared with those of control mice (Figure 6A).
The cumulative distribution illustrated that the most significant
change was in the probability of observing core temperature
between 35.5 and 36◦C, but without a change in the minimum or
maximum temperatures (Figure 6B). Furthermore, during the
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FIGURE 3 | Reducing transmitter release from NOS1 neurons in MnPO/MPO hypothalamus alters sleep amounts and the number of sleep episodes in a manner
dependent on the light-dark cycle. (A) Schematic of the stereotaxic injection of AAV-flex-GFP-TeLC into the MnPO/MPO area of Nos1-CRE mice to generate
Nos1-MnPO/MPO-GFP-TeLC mice. (B) Example histology from MnPO/MPO showing expression of the GFP-TeLC protein as detected with a GFP antibody; left
picture, lower magnification view, scale bar is 200 µm, right picture, higher magnification view, scale bar 100 µm. (C) Quantification of sleep states for each mouse
in the 12-h light or dark periods shown as average time in vigilance state per hour. Wakefulness in the light phase (two-tailed t-test, n = 7 and n = 10, p = 0.003),
NREM in the light phase (two-tailed t-test, n = 7 and n = 10, p = 0.0006), NREM in the dark phase (two-tailed t-test, n = 7 and n = 10, p = 0.018). (D) The number
of episodes of wake, NREM and REM between light and dark. REM in the dark phase (two-tailed t-test, n = 7 and n = 10, p = 0.003). (E) Analysis of sleep
transitions between sleep states in the light phase. No differences were observed between groups. (F) The transitions between Nos1-MnPO/MPO-GFP-TeLC mice
and Nos1-MnPO/MPO-GFP mice in the dark phase. Transitions from NREM to REM (p = 0.025) and from REM to wake (p = 0.031), from two-tailed t-test, n = 7
and n = 10. Multiple comparisons were accounted for using the Benjamini-Hochberg procedure at a false discovery rate of 5%. *P < 0.05, **P < 0.01, N.S, not
significant.
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FIGURE 4 | Distribution of sleep episode lengths is reduced for Nos1-MnPO/MPO-GFP-TeLC mice during wakefulness in the light period but increased in
wakefulness in the dark period. (A) Wakefulness in the light period binned by episode length. No differences are seen in bins less than 20 min. Episodes greater than
20 min in Nos1-MnPO/MPO-GFP-TeLC mice (n = 7 TeLC and n = 10 GFP, p = 0.02). (B) NREM in the light period binned by episode length. No differences are
seen in bins less than 10 min (n = 7 TeLC and n = 10 GFP). (C) Light phase REM. No differences are seen in bins less than 4 min (n = 7 TeLC and n = 10 GFP).
(D) Dark phase wakefulness. No differences are seen between groups within each light cycle (n = 7 TeLC and n = 10 GFP). Inset graph, between the light periods
Nos1-MnPO/MPO-GFP and Nos1-MnPO/MPO-GFP-TeLC groups as a paired difference (d, inset graph, n = 7 TeLC and n = 10 GFP, p = 0.036). (E) Dark phase
NREM. No differences are seen in bins less than 10 min (n = 7 TeLC and n = 10 GFP). (F) Dark phase REM. No differences are seen in bins greater than 1 min.
Episodes of less than 1 min are significant between Nos1-MnPO/MPO-GFP-TeLC and Nos1-MnPO/MPO-GFP mice (n = 7 TeLC and n = 10 GFP, p = 0.008).
Multiple comparisons were accounted for using the Benjamini-Hochberg procedure at a false discovery rate of 5%. *P < 0.05, **P < 0.01, N.S, not significant.
dark phase, while Nos1-MnPO/MPO-GFP control mice dropped
their core temperature, Nos1-MnPO/MPO-GFP-TeLC control
mice did not, both during the middle of the dark phase and
prior to the next lights-on period (Figures 6C,D); furthermore,
during the siesta period Nos1-MnPO/MPO-GFP-TeLC mice
spent 36% less total time in NREM sleep compared with control
mice, although there were no significant changes in NREM sleep
episode count or mean length (Figure 6E).
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FIGURE 5 | NOS1 neurons in MnPO/MPO contribute to theta power during
REM sleep. (A) Normalized power for NREM during the light period shown as
a power spectrum. Different frequency bands are also illustrated. (B) For
NREM during the light period, data for individual mice are shown for relevant
frequency bands. (C) REM during the light period. (D) Quantification of
spectral differences during REM in the light period for individual mice show
more δ2 in the TeLC condition (t test, n = 6, TeLC; n = 10, GFP; p = 0.015)
alongside reduced theta (t test, n = 6, TeLC; n = 10, GFP; p = 0.017).
(E) Normalized power for NREM in the dark period shown as a power
spectrum. (F) Data for individual mice are shown for relevant frequency bands
(t test, n = 6, TeLC; n = 10, GFP; p = 0.048). (G) REM during the dark
period. (H) Quantification of spectral differences during REM in the light period
for individual mice (δ2 between groups, t test, n = 6, TeLC; n = 10, GFP;
p = 0.017). Theta between groups (t test, n = 6, TeLC; n = 10, GFP;
p = 0.013). Multiple comparisons were accounted for using the
Benjamini-Hochberg procedure at a false discovery rate of 5%. *P < 0.05, n.s,
not significant.
DISCUSSION
In this study we have discovered that many NOS1 cells in the
midline PO hypothalamus are naturally sleep-active, although
there seemed to be several different categories of responses and
probably several different types of cell. Based on their calcium
signals, the fast and transient “sharp” activations of these NOS1
cells from wake to NREM and the slower, prolonged “soft”
transitions from wake to NREM may represent two populations
of sleep-active NOS1 neurons. However, the cells are not active
throughout NREM sleep, but instead are most active at the
transitions from wake to NREM and the subsequent first part
of NREM. They also become active during the later parts of
REM sleep. The “sharp transition” subgroup is more likely to
play a role in sleep onset, whereas the other groups appear to
be following with their activity after NREM and REM sleep are
established. The cells are not silent during wake periods, but
their activity is intermittent. A minority (10%) of these NOS1
cells show no change in their calcium signals at the transitions
of the vigilance states, again suggesting subtypes of cells. We
used TeLC expression in NOS1 neurons to disrupt their synaptic
activity, which in turn disrupted the sleep-wake profile of the
mice in a manner that varied with the light or dark phases of
the 24-h cycle. In the dark phase, mice with TeLC expressed
in MnPO/MPO NOS1 neurons showed a reduction of time in
NREM sleep and a loss of the shortest REM episodes; NREM
to REM and REM to wake transitions were also reduced. REM
sleep was accompanied by increased delta power and decreased
theta power, possibly suggesting functional disruption of REM
sleep. In the lights-on phase, however, there was an increase in
NREM sleep, but REM sleep was unchanged. Overall, the mice
were chronically warmer.
Our new results are consistent with our previous work
on these cells. We have previously shown that a subset of
MnPO/MPO glutamate/NOS1 neurons, when activity-tagged
following an external warm-stimulus to the mice, could on
reactivation induce NREM sleep and concomitant body cooling
(Harding et al., 2018). Similarly, a GABAergic MnPO/MPO
population, tagged in the same manner, could only induce
sleep (Harding et al., 2018). As we did not observe overlap
in these populations by immunohistochemistry, we suggested a
model of external warmth-triggered sleep with a NOS1/glutamate
(MnPO/MPO) population signaling to a downstream GABAergic
population in MPO (Harding et al., 2020). Thus MnPO/MPO
NOS1 neurons can sense changes in temperature although we
do not know if this is direct sensing or through afferents from
the skin. In Nos1-MnPO/MPO-GFP-TeLC mice, contrary to the
expectation that NREM sleep would be unchanged or reduced
during the light phase, these mice had an increase in the light
phase, and a subsequent reduction in this state during the dark
phase. So, it is possible that these changes in sleep-wake states
result from the altered thermoregulation, or the effect is complex
because of the likely multiple subtypes of cell. The effects on
REM sleep (selective for the dark phase) were unanticipated,
but perhaps not surprising given that REM sleep is partly
controlled by unknown cell types in the MPO area (Suntsova and
Dergacheva, 2004; Gvilia et al., 2006), and we have presumably
influenced a NOS1 cell subtype involved in REM production.
Alternatively, the reduction in REM sleep when NOS1 neurons
are blocked might be linked to the reduction of NREM sleep,
which both happen in the dark phase, and not as a result of a
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FIGURE 6 | NOS1 neurons in MnPO/MPO hypothalamus act to reduce body temperature. (A) Aggregated temperature data from 7 days of recording for each
mouse averaged by ZT time at 2-min intervals to produce a ‘typical’ day histogram, averaged for each group (rmANOVA, n = 4, TeLC; n = 6, GFP;
temperature × group at 35.4–35.6◦C, p = 1.97 × 10−4). (B) Cumulative frequency of temperature distribution. (C) Temperature profile over 24 h. (D) Quantification
of 24-h temperature profile in the light and dark phase (two-tailed t test assuming unequal variance, n = 4, TeLC; n = 3, GFP; p = 0.041). (E) Percentage sleep and
episode count and episode length a ‘siesta’ period between ZT 16–20 (two tailed t-test, n = 7 and n = 10, p = 0.01). *P < 0.05, N.S, not significant.
REM-specific mechanism. This idea is consistent with a lower
theta power during REM, which may indicate reduced REM
sleep propensity.
Initially, given that nos1 gene expression in the
MPO hypothalamus has a highly restricted expression
pattern, as detected by both in situ hybridization and
immunohistochemistry (see e.g., Figure 4E in Harding
et al., 2018), we anticipated that nos1 expression would be
a pragmatic and useful marker for functional manipulation
of a unique subset of cells. Unfortunately, this has turned
out not to be the case. While many of the NOS1 neurons in
MPO studied by calcium photometry have clear sleep-active
patterns, it has become apparent since we started our work
that multiple subtypes of NOS1 neuron exist in the PO area,
including NOS1/VGLUT2, NOS1/VGAT, NOS1/galanin neurons
and others (Moffitt et al., 2018). The bidirectional changes in
sleep when TeLC is expressed in MnPO/MPO NOS1 neurons
likely reflect the reduced synaptic transmitter release from
multiple subtypes of NOS1 cell in MnPO/MPO. For example,
activation of glutamate (VGLUT2) neurons in the PO area
induces wakefulness (Vanini et al., 2020), so if this particular
subset were to express the nos1 gene, TeLC expression in
them might reduce wakefulness; on the other hand, we have
shown previously that nos1-expressing GABA cells induce
NREM sleep (Harding et al., 2018); thus TeLC expression in
NOS1 cells might promote wakefulness (Harding et al., 2018).
Further progress to dissect this circuitry requires intersectional
genetics. Nevertheless, it remains striking that the majority of
MnPO/MPO NOS1 cells have most of their activity during the
transitions from wake to NREM sleep, and during the later parts
Frontiers in Neuroscience | www.frontiersin.org 10 October 2021 | Volume 15 | Article 709825
fnins-15-709825 October 9, 2021 Time: 16:13 # 11
Harding et al. Sleep-Active Nitric Oxide Synthase Neurons
of REM sleep episodes. Targets for NOS1 neurons could include
GABAergic and galaninergic neurons in the LPO area that are
involved in NREM sleep induction and maintenance (Kroeger
et al., 2018; Ma et al., 2019), as well as uncharacterized long-
range targets. Although we always used the same coordinates,
we did not attempt to distinguish NOS1 cells in the small and
neighboring MnPO and MPO areas.
Expressing TeLC in MnPO/MPO NOS1 neurons raised the
average body temperature of the mice. This would be consistent
with effects on temperature mediated by BDNF/PACAP or
TRPM2 expressing neurons in the MPO area (Song et al., 2016;
Tan et al., 2016; Harding et al., 2018); these neurons could co-
express NOS1. There are also glutamatergic wake-promoting
neurons in the PO that are associated with mild body cooling
of approximately 1◦C that could also have a role (Vanini et al.,
2020), and may also express the nos1 gene. However, unlike the
effects on temperature produced by BDNF/PACAP or TRPM2
cells, the increases we see appear to be associated with the light
phase of the dark-light cycle, specifically in the siesta period
(ZT16-20) and the period before the dark-to-light transition.
Thus, MnPO/MPO NOS1 cells are driving down temperature at
the same time as NREM sleep is initiated, consistent with our
earlier work (Harding et al., 2018). Overall, this may support a
larger hypothesis on optimization of sleep for energy reallocation
(Harding et al., 2020).
In summary, we have found that the activity pattern of some
MnPO/MPO NOS1 cells is quite striking, being rather selective
at the boundary between wake to NREM transitions and the later
part of REM sleep, and that synaptic transmission from PO NOS1
neurons likely contributes to NREM and REM sleep organization,
as well as chronic body cooling. We write “likely” because we have
not formally shown that TeLC expression reduced transmitter
release in these neurons, and we have not identified post-synaptic
targets of MnPO/MPO NOS1 cells. We currently think that
MnPO/MPO NOS1 neurons probably have both short local
outputs and long-range connections where transmitters could be
released. A further caveat is that NO itself is likely to be part
of the signaling system from these cells. We did not address
this because NO release from cells is independent of vesicle
release. But as NOS1 synthase is calcium-dependent (Knowles
and Moncada, 1994), periods of elevated calcium seen in NOS1
neurons at the wake to NREM transitions and during NREM
sleep will result in NO release from these cells, and NO could well
be influencing sleep structure and temperature regulation. We
further speculate that NOS1 neurons, possibly using NO release,
may have a role in controlling vasodilation specifically in the
context of sleep. We should bear in mind that we have only looked
at male mice, and because the PO area is sexually dimorphic,
NOS neurons could differ in their effects between the sexes.
Given the rather precise calcium activity of some MnPO/MPO
NOS1 cells at the boundary of wake to NREM transitions, further
dissection will likely reveal part of a regulatory circuit controlling
sleep induction/maintenance and the simultaneous lowering of
body temperature.
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